Global Adenomyosis Treatment Market Research Report -Forecast to 2023

Global Adenomyosis Treatment Market Research Report -Forecast to 2023

ID: MRFR/HC/2331-HCRR | November, 2018 | Region: Global | 76 pages | Half-Cooked Research Reports

Global Adenomyosis Treatment Market information, by type (Focal, Adenomyoma, Diffuse and others), by diagnosis (Endometrial biopsy, Ultrasound, Magnetic resonance imaging (MRI), and others), by Treatment (Anti-inflammatory drugs, Hormone medications, Hysterectomy, and others) - Forecast to 2023

Market Synopsis of Global Adenomyosis Treatment Market:

Market Scenario:

Adenomyosis disorder also known as Endometriosis interna, Adenomyosis uteri, Endometriosis uterine, or Adenomyometritis. Adenomyosis disorder occurs when endometrial tissue of the uterus endometrial cavity to grow into the uterus muscle that damage the uterine wall the uterine wall grow thicker. It may result into heavy bleeding and pain during the menstrual cysle. Increasing prevalence of adenomyosis is leading the market growth. Rising prevalence of adenomyosis disorder is key factor for the market growth. Increasing knowledge about the disorder and treatment, new drugs and therapies, and advanced medical technology are major driving forces of the global adenomyosis market. Increasing funding for R&D to develop more advanced product for the market is another key driver for the market.

The Global Adenomyosis Treatment market is growing at the CAGR of ~4.1% during the forecast period and expected to reach US$ 291.5 million by 2023.

Study objectives of Global Adenomyosis Treatment Market:

  • To provide detailed analysis of the Global adenomyosis treatment market structure with historical and forecast revenue for the next 7 years of the various segments and sub-segments of the adenomyosis treatment market

  • To provide insights about the key drivers, restraints, opportunities and challenges that affecting the growth of the adenomyosis treatment market

  • To provide analysis of the market with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detail analysis of the market that segmented on the basis of type, by diagnosis, by treatment, and its sub-segments.

  • To provide detail analysis of global adenomyosis Treatment market mainly based on value chain adenomyosis analysis, Porter’s five forces, Price analysis, and Supply Chain analysis etc.

  • To provide detail country level analysis of the market with respect to the current market size and future prospective

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global adenomyosis Treatment Market

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the Adenomyosis Treatment market



Key Players for Global Adenomyosis Treatment Market:                          

Some of the key players in this market are: Bayer AG (Germany), Ferring B.V. (Switzerland), Johnson & Johnson Consumer Inc. (US), Novartis (Switzerland), Merck KGaA (Germany), Pfizer Inc. (US), Speciality European Pharma (UK)


Global adenomyosis treatment Market has been segmented on the basis of type which Focal, Adenomyoma, Diffuse, and others. On the basis of diagnosis, it is segmented into endometrial biopsy, ultrasound (transabdominal, transvaginal/endovaginal), and magnetic resonance imaging (MRI). On the basis of treatment, the market is segmented into anti-inflammatory drugs (ibuprofen, Motrin IB, Advil, and others), hormone medications (Gonadotropin-releasing hormone (GnRH) agonists, Aromatase inhibitors), Hysterectomy (supracervial or subtotal hysterectomy, Total hysterectomy, Radical hysterectomy), and others.

Research Methodology:

 Sources: Directorate of Industries, Annual report, White paper, Company Presentation


Regional Analysis of Global Adenomyosis Treatment Market:                        

Considering the global scenario of the market, due to continuous innovation and rapid adoption of new drugs and therapies, North America is largest market for Adenomyosis Treatment. US is holding largest market share in North America region. European market is second largest, and especially the growth rate is higher in west European countries. On the other hand, due increasing knowledge of disease and treatments, developing healthcare infrastructure, and increasing healthcare expenditure, the Asia-Pacific (APAC) is fastest growing market for adenomyosis and expected to grow significantly during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of devices and treatment. 

Intended Audience

  • Adenomyosis Treatment drugs manufacturers

  • Adenomyosis Treatment drugs providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

Table of Content

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market trends

5.7.2 Technological trends

5.7.3 Insurance & Regulations

5.7.4 Others

6. Global Adenomyosis Treatment Market by Type

6.1 Focal

6.2 Adenomyoma

6.3 Diffuse

6.4 Others

7. Global Adenomyosis Treatment Market by Diagnosis

7.1 Endometrial biopsy

7.2 Ultrasound

7.2.1 Transabdominal

7.2.2 Transvaginal/endovaginal

7.3 Magnetic resonance imaging (MRI)

7.4 Others

8. Global Adenomyosis Treatment Market by Treatment

8.1 Anti-inflammatory drugs

8.1.1 Ibuprofen

8.1.2 Motrin IB

8.1.3 Advil

8.1.4 Others

8.2 Hormone medications

8.2.1 Gonadotropin-releasing hormone (GnRH) agonists

8.2.2 Aromatase inhibitors

8.2.3 Others

8.3 Hysterectomy

8.3.1 Supracervial or subtotal hysterectomy

8.3.2 Total hysterectomy

8.3.3 Radical hysterectomy

8.4 Others

9. Global Adenomyosis Treatment Market by Region

9.1 Introduction

9.2 America

9.2.1 North America The US Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe Germany France Italy Spain UK Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia

9.4.1 China

9.4.2 India

9.4.3 Japan

9.4.4 South Korea

9.4.5 Rest of Asia

9.5 Pacific

9.6 Middle East and Africa

9.6.1 UAE

9.6.2 Saudi Arabia

9.6.3 Egypt

9.6.4 Rest of Middle East and Africa

10. Competitive landscape

11. Company profile

12 Conclusion

12.1 Key findings

10.1.1 From CEO’s viewpoint

10.1.2 Unmet needs of the market

12.2 Key companies to watch

12.3 Prediction of Adenomyosis Treatment Market

13 Appendix